Either you do not have the newest version of Adobe Flash®, or you have JavaScript disabled.

Please ensure you have these capabilities.

RELEASES

  • For further information contact:
    Fred Iannotti
    802-888-0085
    fiannotti@planningsource.com

    Trimira Clinical Training Video for Identafi 3000 Ultra Developed by Author/Instructor Dr. L. Don Wilson – Online Video Delivers Instruction in Use of "Multispectral" Technology

    HOUSTON, Oct. 21, 2009 — Instructor, author, and laser dentistry expert Dr. L. Don Wilson, DDS, has created an online clinical training video for Trimira® LLC's award-winning Identafi® 3000 ultra — the only oral cancer detection device to feature the breakthrough optical system for early detection called "multispectral" technology.

    Identafi® Clinical Training Video
    www.trimira.net/media/training

    Intended for dentists, periodontists, oral surgeons, otolaryngologists, and primary-care physicians, the video shows users how to optimize Identafi® 3000 ultra's brilliant white, violet, and green-amber illumination. Created exclusively for intraoral use, the cordless Identafi® 3000 ultra is lightweight, portable, and ergonomically shaped; it incorporates a nickel-plated design that improves durability and delivers a smoother feel. The handheld is portable, and thus is readily moved from room to room and patient to patient.

    Identafi® 3000 ultra's high-speed, high-resolution, triple-wavelength fluorescence and reflectance spectroscopy is highly effective in screening oral cancers; the same science works in diagnosing cervical, skin, gastrointestinal, and bladder cancers. Developed by three institutions — The University of Texas, M.D. Anderson Cancer Center; Rice University; British Columbia Cancer Research Centre — it represents a quantum leap in the visualization of mucosal abnormalities, including cancer or premalignant dysplasia.

    Identafi® 3000 Ultra
    www.trimira.net/identafi

    Identafi® 3000 ultra delivers a higher degree of clinical accuracy and confidence to users, which translates into better patient care. Its patented multispectral technology minimizes false positives and reveals abnormalities in oral tissue missed by the naked eye. Unlike other methods, Identafi® 3000 ultra empowers doctors and dentists to pinpoint biochemical and morphological changes in cells. Identafi® 3000 ultra's violet wavelength capability was cited in the May 2009 issue of Cancer Prevention Research, the journal of the American Association for Cancer Research, as the best excitation wavelength to discriminate between neoplastic and non-neoplastic tissue areas.

    Wilson has been in private dental practice for 30 years, recently opening his newest practice in Florence, Alabama. He has been a featured speaker in such venues as The Star of the South Dental Meeting, the Mid-South Dental Congress, the Northern Virginia Dental Society, and the Annual International Meeting of the Academy of Laser Dentistry. He also has served as one of the featured speakers for laser training at the renowned Las Vegas Institute. He has conducted more than 300 seminars in 26 states and is an instructor for cosmetic laser dentistry courses at the acclaimed Nash Institute in Charlotte.

    Wilson has written several articles on laser dentistry, including laser practice management articles for industry journals Dental Economics and The Incisal Edge. He is an instructor and user of both the Erbium, Chromium: YSGG laser and diode laser. He is a member of the Academy of Laser Dentistry, where he holds the Standard Proficiency Certification, Advanced Proficiency Certification, and Educator Status. Wilson is also the featured clinician in a Erbium Laser Training DVD, Group Practice DVD, and an Oral Cancer Screening Device DVD. He has also co-written award-winning laser dentistry advertisements that have appeared nationally.

    About Trimira LLC

    Trimira® LLC is venture capital-funded by Dallas cancer research philanthropist T. Boone Pickens, of oil and windfarming fame. Other Trimira® sister subsidiaries are working on screening and diagnostic devices for skin, cervical, gastrointestinal, and bladder cancers. Remicalm®, as the parent company, has licensed exclusive use of certain of its patents and patents pending for use as a cervical cancer product to be later expanded to include additional epithelial-based cancers. Remicalm®'s core technologies are based on high-speed, high-resolution capabilities from its patented optical processing technology platforms and include the ability to read metabolic and physiologic differences in diseased and healthy tissue in the human body.

    Visit Trimira® at: http://www.trimira.net/

Animations

Identafi® Technology



Identafi® 3000 ultra Process



Screening Results



Training